Skip to main content
Caplight Logo









Tianjin Hengyu Medical Technology Co., Ltd.

Tianjin Hengyu Medical Technology Co., Ltd.

Private
TianjinHealthcare & Life Scienceshttps://horimedtech.com/

Last Round

Strategic

Apr 21, 2026

Total Funding Raised

$42M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Tianjin Hengyu Medical Technology Co., Ltd. is a medical technology company that develops and manufactures cardiovascular imaging equipment and catheters, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT) systems.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

intravascular ultrasoundIVUSoptical coherence tomographyOCTpercutaneous coronary interventionPCIcardiovascular imagingmedical imaging hardwareimaging cathetersinterventional cardiologymedical device manufacturervascular imagingcoronary artery imagingmedtechcardiac cath lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tianjin Hengyu Medical Technology Co., Ltd. Comparables

Compare Tianjin Hengyu Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Tianjin Hengyu Medical Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hengsheng Medical Group
92%
Insight Lifetech
88%
Shenzhen Vivolight Medical Device & Technology Co., Ltd.
84%

Tianjin Hengyu Medical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicApr 21, 2026
Series D ExtensionDec 8, 2025
Early FundingFeb 20, 2025
Early FundingMar 22, 2024
Series DNov 1, 2023
Early Funding
Jul 18, 2023

Tianjin Hengyu Medical Technology Co., Ltd. Investors

Notable investors and investment history

Tianjin Hengyu Medical Technology Co., Ltd. investors
InvestorRounds
CCIC CapitalStrategic
YuanBio Venture CapitalEarly Funding
Beiyang Haitang Venture Capital FundEarly Funding, Series D
Tasly CapitalSeries C Extension, Early Funding, Series C
Wuxi Venture Capital GroupStrategic
Huatai Zijin InvestmentEarly Funding, Series C Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Raised $14M led by CCIC Capital and Wuxi Venture Capital Group.

  • Dec 8, 2025

    $14.2M raised in Series D Extension round.

Tianjin Hengyu Medical Technology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Tianjin Hengyu Medical Technology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tianjin Hengyu Medical Technology Co., Ltd.'s valuation, stock price, and market status.

Is Tianjin Hengyu Medical Technology Co., Ltd. a public or private company?

Tianjin Hengyu Medical Technology Co., Ltd. is a private company.

What is the current stock price of Tianjin Hengyu Medical Technology Co., Ltd.?

Tianjin Hengyu Medical Technology Co., Ltd. is a private company with no public stock price. Caplight tracks Tianjin Hengyu Medical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Tianjin Hengyu Medical Technology Co., Ltd. worth (valuation)?

Valuation information for Tianjin Hengyu Medical Technology Co., Ltd. is not publicly available.

Can I buy Tianjin Hengyu Medical Technology Co., Ltd. stock?

Tianjin Hengyu Medical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Tianjin Hengyu Medical Technology Co., Ltd.'s last funding round?

Tianjin Hengyu Medical Technology Co., Ltd.'s most recent funding round was Strategic on April 21, 2026.

Who are the main investors in Tianjin Hengyu Medical Technology Co., Ltd.?

Key investors in Tianjin Hengyu Medical Technology Co., Ltd. include CCIC Capital, Tasly Capital, Wuxi Venture Capital Group, Huatai Zijin Investment.

Will Tianjin Hengyu Medical Technology Co., Ltd. IPO soon?

No public IPO plans have been announced for Tianjin Hengyu Medical Technology Co., Ltd..

How can I track Tianjin Hengyu Medical Technology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tianjin Hengyu Medical Technology Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTianjin
Year Founded2016
Last FundingApr 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?